Fingerprint changes among cancer patients treated with paclitaxel
Fingerprints have long been used for personal identification; however, some case reports suggested that some chemotherapy agents such as paclitaxel lead to fingerprints loss due to hand-and-foot syndrome (HFS).
This case–control study was performed on 65 patients who received chemotherapy regimens with/without paclitaxel. Patients with the history of receiving any drugs with significant HFS adverse effect or patients with any conditions that affect fingerprints were excluded. Baseline and post-chemotherapy images of fingerprint examples were referred to the Iranian Society of Legal Medicine to compare changes in the fingerprints.
Thirty-one patients entered in the paclitaxel and 34 subjects in the control groups. Seventeen patients (54.8%) in the paclitaxel group experienced fingerprint changes, whereas no patient had fingerprint changes in the control group. By physical examination, no patients in the two groups experienced HFS. After adjusting for age, sex, occupation, and cancer type, there was a significant difference between the two groups regarding fingerprint changes (P = 0.002, OR 13.69, 95% CI 2.05 to infinite).
Considering that fingerprint recognition has been utilized in both government and civilian investigation, patients taking paclitaxel and centers necessitating fingerprint identification should be informed about possible fingerprint changes by paclitaxel.
KeywordsFingerprint changes Paclitaxel Hand-and-foot syndrome (HFS) Fingerprint recognition
Compliance with ethical standards
Conflict of interest
All authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Bardale R (2011) Principles of forensic medicine and toxicology. Jaypee Brothers Medical Publishers (P) Ltd, New DelhiGoogle Scholar
- Chirillo J, Blsul S (2003) Implementing biometric security. Wiley, Hoboken. ISBN 978-0-7645-2502-6Google Scholar
- Common terminology criteria for adverse events, version 4.03, June 2010, National Institutes of Health, National Cancer Institute, file:http//www.evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf
- De Arila D, Dominguez JD, Iglesias L (1996) Taxol-induced acral erythema. Dermatology 192:377–378Google Scholar
- Hirji KF (2005) Exact analysis of discrete data. Chapman and Hall/CRC Press, Boca Raton, FLGoogle Scholar
- Haber R, Helou J, Korkomaz J, Habre M, Ghanem A, Tomb R (2015) Absence of fingertips with focus on dermatological etiologies: national survey and review. Clin Dermatol 3(1):21–26Google Scholar
- Jain AK, Flynn P, Ross AA (2008) Handbook of biometrics. Springer, Berlin. ISBN 978-0-387-71040-2Google Scholar
- Lacy CF, Armstrong LL, Goldman MP, Lance LL (eds) (2011) Drug information handbook, 20th edn. Lexi-Comp, HudsonGoogle Scholar
- R Core Team (2014) R: a language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria. http://www.R-project.org/
- Yarbro CH, Frogge MH, Goodman M (eds) (2004) Cancer symptom management, 3rd edn. Jones and Bartlett Publishers, SudburyGoogle Scholar